DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer
Go back to DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer| (NASDAQ: DMAC) | Delayed: 6.33 -0.14 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.47 | 52 Week High | $ | |||
| Open | $6.57 | 52 Week Low | $ | |||
| Day High | $6.88 | P/E | N/A | |||
| Day Low | $6.33 | EPS | $ | |||
| Volume | 57,102 | |||||

